Pharmaceuticals #peptides#pharmaceuticals
Peptide Manufacturing Capacity Investments Surge Ahead of FDA Reclassification Decision
Telehealth companies and compounding pharmacies are investing in peptide manufacturing capacity ahead of a pivotal FDA reclassification meeting on July 23-24. Hims & Hers Health purchased a peptide manufacturing facility in February 2025, while Olympia Pharmaceuticals has spent heavily on formula development. Testing investments exceed $100,000 per product.
Jul 21, 2026 1 source